Oncolytic Therapy for Melanoma
Oncolytic therapy was first introduced in the field of oncology a decade ago. Recently, advancements have been made in oncolytic therapy, with the promise of potentially transforming the melanoma treatment landscape. In anticipation of an expanded role for oncolytic therapy, providers need updates on the mechanism of action, efficacy, safety, and practical aspects of each regimen. Advanced practice providers often spearhead the adoption of technologies such as intralesional injections in health systems. Therefore, they need up-to-date education about oncolytic therapies, opportunities to develop competency in intralesional injections, as well as support for credentialing. This curriculum, which carries the Advanced Practitioner Society for Hematology and Oncology (APSHO) Seal of Acceptance, contains didactic content on oncolytic therapies, instructional videos on techniques for intralesional injections, supportive strategies for credentialing, as well as a future opportunity for hands-on training for intralesional injections at JADPRO Live. We trust that you will find this content helpful in the adoption of an expanded role for oncolytic therapies in melanoma.
What You’ll Learn:
- Understand the mechanism of action and clinical data behind oncolytic therapies
- Compare different oncolytic agents and their applications in melanoma
- Master intralesional injection techniques through instructional videos
- Communicate effectively with patients receiving oncolytic therapy
- Navigate the credentialing process with confidence
- Prepare for hands-on training opportunities at JADPRO Live. Learn more about this training opportunity!
Course Format:
- Mode: Interactive text plus video
- 1.5 CE hours. Course is accredited in ANCC, ACPE, and ACCME.
Cost: Free
Meet the Presenters:
| Lisa Kottschade, APRN, MSN, CNP, FAPO | Margaret "Meg" Leddy, PA-C, MMSc | Suzanne McGettigan, MSN CRNP AOCN® |
This educational activity is hosted by one of APSHO’s educational partners.
Additional login may be required.
This activity is provided by Partners for Advancing Clinical Education (Partners); Terranova Medica, LLC; Advanced Practitioner Society for Hematology and Oncology (APSHO); and Integrita Healthcare Education Foundation and supported by an educational grant from Replimune.
